As EMA and the European Commission are preparing a series of Brexit guidance documents, companies should check the EMA’s website regularly for guidance on the consequences of Brexit. EMA recently informed that will survey pharma companies on their preparedness for Brexit and yesterday the second revision of the Q&A on Brexit Regulatory Guidance was released. If you need support we’ll be happy to help.